Please login to the form below

Not currently logged in
Email:
Password:

Cristal Therapeutics names chief business officer

Neuroscientist Jeroen Tonnaer to take up the position

edit-Cristal-TherapeuticsLife sciences firm Cristal Therapeutics has named Jeroen Tonnaer as its chief business officer.

Tonnaer joins from Merck Sharp & Dohme, where he was executive director, head European external scientific affairs and worldwide licensing. He will be responsible for the company's business development, partnering and licensing activities.

As a neuroscientist, Tonnaer has expansive experience in the sector, including senior positions such as head of discovery collaborations Europe and Schering-Plough and head of the department of drug metabolism and kinetics at Organon.

He additionally serves as founder and executive consultant for PharmProspect, which helps start-ups and biotech companies work with pharma.

Joost Holthuis, CEO at Cristal Therapeutics, commented: “I am delighted to welcome Jeroen to Cristal Therapeutics and look forward to working with him.

“Jeroen will strengthen our key existing business relationships and focus on finding, executing and fostering new partnering opportunities for Cristal Therapeutics.

Cristal Therapeutics works with a focus on developing novel nanotherapeutics against cancer and other diseases by using its CriPec platform.

27th April 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics